 HOLLISTER, Calif., Aug. 31, 2022 GLOBE NEWSWIRE -- Alpha Teknova, Inc. Teknova Nasdaq: TKNO, a leading provider of critical reagents for the discovery, development, and commercialization of drug therapies, novel vaccines, and molecular diagnostics, today announced that the Company will participate in the following upcoming investor conference. 